Business: Phase 3 biotech developing topical therapies for common skin diseases. Avadim Health - Asheville, N.C., 5 million shares, priced $14-$16, ...
News
- Initial public offerings scheduled to debut next week
- Neighborhood Eats: Feast like a king at Royal Pizza
SAN ANTONIO — What's a guy from Tunisia know about making pizzas in SATX? Basset Ridene said his restaurant training and his homeland make ...
- Researchers uncover two-drug combo that halts the growth of cancer cells
... Ph.D., of the START Center for Cancer Care, San Antonio; Richard E. Cutler Jr., Ph.D., of Puma Biotechnology Inc., Los Angeles; Alshad S. Lalani of ...
- J&J looks to fend off challenges to key drugs, consumer products
"Darzalex is transforming the field of multiple myeloma right now," Jan G. J. van de Winkel, the CEO of Danish biotech Genmab, which collaborated ...
- Johnson & Johnson posts higher sales, big 4Q profit jump
... and other skin disorders, and completed its acquisition of Taris Biomedical, which is developing treatments for bladder disorders, including cancer.